A Butanoic acid, 2-amino-3-methyl-, (S)- CEP of the European Pharmacopoeia monograph is often referred to as a Butanoic acid, 2-amino-3-methyl-, (S)- Certificate of Suitability (COS). The purpose of a Butanoic acid, 2-amino-3-methyl-, (S)- CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Butanoic acid, 2-amino-3-methyl-, (S)- EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Butanoic acid, 2-amino-3-methyl-, (S)- to their clients by showing that a Butanoic acid, 2-amino-3-methyl-, (S)- CEP has been issued for it. The manufacturer submits a Butanoic acid, 2-amino-3-methyl-, (S)- CEP (COS) as part of the market authorization procedure, and it takes on the role of a Butanoic acid, 2-amino-3-methyl-, (S)- CEP holder for the record. Additionally, the data presented in the Butanoic acid, 2-amino-3-methyl-, (S)- CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Butanoic acid, 2-amino-3-methyl-, (S)- DMF.
A Butanoic acid, 2-amino-3-methyl-, (S)- CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Butanoic acid, 2-amino-3-methyl-, (S)- CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Butanoic acid, 2-amino-3-methyl-, (S)- suppliers with CEP (COS) on PharmaCompass.